DRESS syndrome with bilateral panuveitis, elevated intraocular pressure, and HHV-6 reactivation: A case report;DRESS syndrome associé à une pan-uvéite bilatérale: À propos d'un cas

Journal Francais d'Ophtalmologie

Volumn 29, Issue 6, 2006, Pages 659-664

  Schauer, P ^a   Salaun, N ^a   Bazin, S ^a   Labrouze, J M ^a   Bourguignon, G ^a  

^a HÔPITAL D'INSTRUCTION DES ARMÉES ROBERT PICQUÉ   (France)

Author keywords

Bilateral panuveitis with elevated intraocular pressure; DRESS; HHV 6; Hypersensitivity syndrome

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID; IMMUNOGLOBULIN;

ADULT; ARTICLE; CASE REPORT; DRESS SYNDROME; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; HYPOGAMMAGLOBULINEMIA; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; NONHUMAN; PRESCRIPTION; UVEITIS; VIRUS REACTIVATION;

EID: 33746795799     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0181-5512(06)73828-1     Document Type: Article

References (31)

1. Begon E, Roujeau JC. Syndrome d'hypersensibilité médicamenteuse ou DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Ann Dermatol Venereol, 2004;131:293-7.
2. Hamer HM, Morris HH. Hypersensitivity syndrome to antiepileptic drugs: a review including new anticonvulsivants. Cleve Clin J Med, 1999;66:239-45.
3. Callot V, Roujeau JC, Bagot M, Wechsler J, Chosidow O, Souteyrand P, et al. Drug induced pseudolymphoma and drug hypersensitivity syndrome: two different clinical entities. Arch Dermatol, 1996;132:1315-21.
4. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine or sodium valproate: a record linkage study. Neurology, 1997;49:542-6.
5. Mallal S, Nolan D, Witt C, Masel G, Martin AM, Moore C, et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet, 2002;359:727-32.
6. Gennis MA, Vemuri R, Burns EA, Hill JV, Miller MA, Spielberg SP. Familial occurence of hypersensitivity to phenytoin. Am J Med, 1991;91:631-4.
7. Warmock JK, Morris DW. Adverse cutaneous reactions to antidepressants. Am J Clin Dermatol, 2002;3:329-39.
8. Knowles SR, Uetrecht J, Shear NH. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet, 2000;356:1587-91.
9. Eliaszewicz M, Flahault A, Roujeau JC, Fillet AM, Challine D, Mansouri S, et al. Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS. J Am Acad Dermatol, 2002;47:40-6.
10. Hashizume H, Takigawa M, Tokura Y. Characterization of drug-specific T cells in phenobarbital-induced eruption. J Immunol, 2002;168:5359-68.
11. Choquet-Kastylevsky G, Intrator L, Chenal C, Bocquet H, Revuz J, Roujeau JC. Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Br J Dermatol, 1998;139:1026-32.
12. Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun Vignes B, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systematic symptoms. Arch Dermatol, 2001;137:301-4.
13. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsivant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol, 2004;140:183-8.
14. Tohyama M, Hashimoto K. Drug hypersensitivity syndrome and human herpesvirus 6 reactivation. Arch Dermatol, 2002;138:268-9.
15. Wong GA, Shear NH. Is a drug alone sufficient to cause the drug hypersensitivity syndrome? Arch Dermatol, 2004;140:226-30.
16. Offret H, et al. Œil et virus. Rapport de la Société Française d'Ophtalmolgie. Paris, Ed. Masson ; 2000.
17. Ranger-Rogez S, Venot C, Denis F. Human Herpesviruses 6 and 7 (HHV 6 and HHV 7). Rev Prat, 1999;49:2227-31.
18. De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev, 2005;18:217-45.
19. Mizukawa Y, Shiohara T. Virus-induced immune dysregulation as a triggering factor for the development of drug rashes and autoimmune diseases: with emphasis on EB virus, human herpesvirus 6 and hepatitis C virus. J Dermatol Sci, 2000;22:169-80.
20. Kosuge H. HHV 6, 7 and their related diseases. J Dermatol Sci, 2000;22:205-12.
21. Morand JJ, Ligtburn E, Coton T, Carre D, Chouc C, Delorme JM, et al. Syndrome d'hypersensibilité médicamenteuse rapidement résolutif après perfusion d'immunoglobulines humaines. Ann Dermatol Venereol, 2001;128:1351-3.
22. Smith AP, Paolucci C, Di Lullo G, Burastero SE, Santoro F, Lusso P. Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6. J Virol, 2005;79:2807-13.
23. Wright P, Collin JR. The ocular complications of erythema multiforme (Stevens Johnson syndrome) and their management. Trans Ophthalmol Soc UK, 1989;103:338-41.
24. Power WJ, Ghoraishi M, Merayo-Lloves J, Neves RA, Foster CS. Analysis of the acute ophtalmic manifestations of the erythema multiforme, Stevens-Johnson syndrome. Toxic epidermal necrolysis disease spectrum. Ophthalmology, 1995;102:1669-76.
25. Flament J, Storck D, et al. Œil et pathologie géné rale. Rapport de la Société Française d'Ophtalmologie. Paris : Masson ; 1997.
26. Wiersbitzky S, Ratzmann GW, Bruns R, Wiersbitzky H. Reactivation in children of juvenile chronic arthritis and chronic iridocyclitis associated with human herpesvirus6 infection. Pediatr Grenzgeb, 1993;31:203-5.
27. Cano Parra J, Diaz-Llopis M. Drug induced uveitis. Arch Soc Esp Oftalmol, 2005;80:137-49.
28. Fillet AM, Reux I, Joberty C, Fournier JG, Hauw JJ, Le Hoang P, et al. Detection of human herpes virus 6 in AIDS-associated retinitis by means of in situ hybridization, polymerase chain reaction and immunohistochemistry. J Med Virol, 1996;49:289-95.
29. Qavi HB, Green MT, Pearson G, Ablashi D. Possible role of HHV-6 in the development of AIDS retinitis. In Vivo, 1994;8:527-32.
30. Caruso A, Favilli F, Rotola A, Comar M, Horejsh D, Alessandri G, Grassi M, Di Luca D, Fiorentini S. Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures. J Med Virol, 2003;70:451-8.
31. Crane IJ, Kuppner MC, McKillop-Smith S, Knott RM, Forrester JV. Cytokine regulation of RANTES production by human retinal pigment epithelial cells. Cell Immunol, 1998;184:37-44.